Intra-Cellular Therapies, Inc. (ITCI) - Stock Prices, Stock Peers & Analysis

Home
ITCI

Company Name	Intra-Cellular Therapies, Inc.
Symbol	ITCI
Currency	USD
Price	126.2
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	13,407,992,800
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	62.78 - 128
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Dr. Sharon Mates Ph.D.
Website	https://www.intracellulartherapies.com

An error occurred while fetching data.

About Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which